Farallon Capital Management’s Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant CCVI.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-400,000
Closed -$4.02M 327
2021
Q1
$4.02M Buy
+400,000
New +$4.33M 0.02% 198

Other funds holding CCVI.U

Farallon Capital Management's CCVI.U Position: Q2 2021 in Review

Farallon Capital Management sold out of Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant (CCVI.U) in Q2 2021, closing a stake of 400,000 shares — an estimated $4.02M sold.

Farallon Capital Management first reported a position in CCVI.U in Q1 2021 and held it in 1 quarter. The position peaked at $4.02M in Q1 2021. 49 funds tracked by Wall St. Rank hold CCVI.U as of Q2 2021.

  • Farallon Capital Management reported no remaining Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant position as of Q2 2021 after selling out during the quarter.
  • Farallon Capital Management sold 400,000 Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant shares in Q2 2021, an estimated $4.02M.
  • Farallon Capital Management first reported a position in Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant in Q1 2021 and held it in 1 quarter.
  • Farallon Capital Management's Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant position peaked at $4.02M in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant as of Q2 2021.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.